Uniphar Biotech Private Limited

Uniphar Biotech Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2013PTC034725 Incorporated 13 September 2013 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹4.85 Cr
▼ 9% YoY
Net profit · FY 2024
₹12.34 Lakh
Net margin 2.5%
EBITDA · FY 2024
₹21.39 Lakh
EBITDA margin 4.4%
Authorised capital
₹12 Lakh
Registered with MCA
Paid-up capital
₹7.5 Lakh
Issued & subscribed
Satisfied charges
₹5 Lakh
No open charges
Company age
13 yrs
Est. 2013
Directors on board
4
As per MCA filings

About Uniphar Biotech Private Limited

Data last updated:

Uniphar Biotech Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2013PTC034725. Its GSTIN is 04AABCU6253D1ZO (Chandigarh).

The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors including Ashwani Kumar Tejpal and Rajeev Matta.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 296 – 297 1st & 2nd Floor Motor Market Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2024, the company reported a revenue of ₹4.85 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹12.34 Lakh (net margin 2.5%) and EBITDA of ₹21.39 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.

The company is associated with 1 brand: Uniphar Biotech. As per MCA filings, the company has satisfied charges of ₹5 Lakh on record. Court records list 11 cases involving the company, including 11 filed by the company; 2 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.5 Lakh; the latest was in April 2017. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 5 smaller; the largest is Allen's India Ltd. with revenue of ₹4.86 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 64 overdue payments to 7 micro and small suppliers.

Uniphar Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0007033). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unipharbiotech.com.

Company details

CIN U24232CH2013PTC034725
Registration Number 034725
Incorporation Date 13 September 2013
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0007033
Key People
Ashwani Kumar Tejpal Director Rajeev Matta Director Adesh Saini Director

Recognitions & Rankings of Uniphar Biotech

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-CH-01-0007033

Contact details

Uniphar Biotech Private Limited's registered office is in Chandigarh, Chandigarh. Its website is unipharbiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    unipharbiotech.com
  • Registered Address
    Scf 296 – 297 1st & 2nd Floor Motor Market Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Uniphar Biotech Private Limited, buy the company report.

Comprehensive company report
Uniphar Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Uniphar Biotech operates one associated brand: Uniphar Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Uniphar Biotech
Manufactures ethical drugs, offers franchises, and provides contract manufacturing services.unipharbiotech.com

Business activity

The main business activity of Uniphar Biotech is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Uniphar Biotech Private Limited, buy the company report.

Financials of Uniphar Biotech Private Limited

FY 2025 filings available

Uniphar Biotech Private Limited reported revenue of ₹4.85 Cr (down 9% YoY) for FY 2024.

Revenue · FY 2024
₹4.85 Cr ▼ 9%
Net profit · FY 2024
₹12.34 Lakh margin 2.5%
EBITDA · FY 2024
₹21.39 Lakh margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 2%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 11%
5 years · compounded
▲ 13%

Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹21.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.34 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.4%
Net Profit Margin2.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uniphar Biotech Private Limited, buy the company report.

Board of directors of Uniphar Biotech Private Limited

Uniphar Biotech has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashwani Kumar Tejpal
Also directs: Abiz Pharma Private Limited, Logimed Pharma Private Limited
Director12 Apr 20179 Years 6 MonthsCurrent
Rajeev Matta
Also directs: Alester Pharma Private Limited, Abiz Pharma Private Limited, Arovea Lifesciences Private Limited
Director13 Sep 201313 Years 1 MonthsCurrent
Adesh Saini
Also directs: Alester Pharma Private Limited, Abiz Pharma Private Limited, Arovea Lifesciences Private Limited
Director13 Sep 201313 Years 1 MonthsCurrent
Kamna Matta
Also directs: Alester Pharma Private Limited, Abiz Pharma Private Limited
Director13 Sep 201313 Years 1 MonthsCurrent
View all directors

Peer comparison

Uniphar Biotech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Allen's India Ltd.₹4.86 Cr (FY 2024)1.0%Kolkata, West Bengal, India
Uniphar Biotech Private Limitedthis company₹4.85 Cr (FY 2024)₹12.34 Lakh2.5%-9.0%Chandigarh, India
Villmed Laboratories Private Limited₹4.85 Cr (FY 2024)112.0%Selaqui, Uttarakhand, India
Transcure Therapeutics Private Limited₹4.85 Cr (FY 2025)17.0%Ludhiana, Punjab, India
Exhar Formulations Private Limited₹4.84 Cr (FY 2020)21.0%New Delhi, Delhi, India
Sycon Healthcare Private Limited₹4.83 Cr (FY 2024)0.0%Shahabad Markanda, Haryana, India
VRD Pharmaceuticals and Surgicals Private Limited₹4.83 Cr (FY 2024)-20.0%Dibrugarh, Assam, India

To see the full peer comparison of Uniphar Biotech Private Limited, buy the company report.

Auditor

Uniphar Biotech Private Limited is audited by AMARJEET AND PANKAJ ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
AMARJEET AND PANKAJ ASSOCIATESFY 2022014909N

Shareholding

The shareholding of Uniphar Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Uniphar Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹5 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Apr 2022100561490Hdfc Bank Limited₹5 LakhSatisfied

To see the full charge records of Uniphar Biotech Private Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Uniphar Biotech Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.5 Lakh; the latest was in April 2017.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹6.5 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Apr 2017Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2014Funding round₹6.5 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Uniphar Biotech Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 64 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 7)

SupplierAmount dueDue sinceReported on
Ultra Drugs Private Limited
an individual supplier
Merx Healthcare Communications Private Limited
Strausswell Healthcare
Mascot Health Series Private Limited.

To see the full MSME payment records of Uniphar Biotech Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Uniphar Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AABCU6253D1ZOChandigarhActive01 Jul 2017

To see the full GST registrations and return filing status of Uniphar Biotech Private Limited, buy the company report.

Recent activity

Uniphar Biotech Private Limited has 6 board changes on record since 2013: 4 appointments and 2 cessations. The latest: Ashwani Kumar Tejpal ceased to be Additional Director on 29 Sep 2017.

AGM
Uniphar Biotech Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Uniphar Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 04 Apr 2022 via Charge ID 100561490 with Hdfc Bank Limited was fully satisfied on 19 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Lakh with Charge ID 100561490 was registered on 04 Apr 2022.
Ceased
Ashwani Kumar Tejpal ceased to be Additional Director.
Appointed
Ashwani Kumar Tejpal was appointed as Director.
Ceased
Kanta Tejpal ceased to be Director.
Appointed
Adesh Saini was appointed as Director.
Appointed
Kamna Matta was appointed as Director.
Appointed
Rajeev Matta was appointed as Director.
Incorporation
13 Sep 2013
Uniphar Biotech Private Limited was registered on 13 Sep 2013 with Roc Chandigarh & aged 13 years 1 month as per MCA records.

News

Frequently asked questions

Uniphar Biotech is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2013 (13+ years old) and is registered under CIN U24232CH2013PTC034725.

Uniphar Biotech has 4 current directors:

The latest financial statements of Uniphar Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Uniphar Biotech is 04AABCU6253D1ZO, registered in Chandigarh.

The CIN (Corporate Identification Number) of Uniphar Biotech is U24232CH2013PTC034725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uniphar Biotech has 11 court cases on record: 11 filed by the company. 2 are pending.

Uniphar Biotech was incorporated on 13 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.

Uniphar Biotech has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.5 Lakh; the latest was in April 2017.

The peers of Uniphar Biotech by revenue are Allen's India Ltd, Villmed Laboratories Private Limited, Transcure Therapeutics Private Limited, Exhar Formulations Private Limited, Sycon Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Ashwani Kumar Tejpal ceased to be Additional Director on 29 Sep 2017. Ashwani Kumar Tejpal was appointed as Director on 12 Apr 2017. Kanta Tejpal ceased to be Director on 12 Apr 2017. Uniphar Biotech has 6 board changes on record in total.

Yes, Uniphar Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0007033).

Uniphar Biotech has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 64 overdue payments to 7 micro and small suppliers. The latest return was filed on 23 May 2019.